PROCEPT BioRobotics Reports Q1 2026 Revenue Growth and Operational Improvements
PROCEPT BioRobotics reported Q1 2026 revenue of $83.1 million, a 20% increase year-over-year, driven by higher U.S. procedures and improved pricing discipline. The company reiterated its full-year revenue guidance and highlighted progress in operational efficiency and profitability.
Tickers: $PRCT
Topics: Clinical Milestones Earnings Financial Performance Pricing Strategy Revenue Growth